We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Systematic review shows potential benefits of combining thrombopoietin receptor agonists with immunosuppressive therapy in aplastic anaemia, highlighting treatment options.
The authors have confirmed clinical trial registration is not needed for this submission.
No takes yet. Share an insight, caveat, or question.
Ashrafi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: